The Roche and GSK-backed autoimmune disease drug developer has gone public in an upsized initial public offering after at least $138m in earlier funding.

Two fintech companies floated in early July 2020, giving an exit to corporate backers in what has been a good year for the sector.

The oncology therapy developer has gone public in an upsized offering that provided an exit to Third Rock Ventures.

The EV battery producer has gone public in China, weeks after raising $193m in a round featuring strategic partner Daimler.

The oncology therapy developer has gone public in an upsized offering that provided exits for SoftBank Vision Fund and Alphabet's GV unit.

The ophthalmologic drug developer has gone public three years after being founded by WuXi AppTec-backed 6 Dimensions Capital.

The banking software provider's shares have nearly tripled following an offering in which it floated well above its range.

The online employee and further education provider has listed on TSE’s Mothers Market, allowing Tokyo Institute of Technology to exit.

The online retail software provider, which has raised $219m in venture funding from investors including Telstra, Softbank and American Express, set a $100m target.

The Baidu and SoftBank-backed on-demand staff provider floated in the middle of its range in a US offering and its market cap currently stands at about $600m.